Genistein has prevented epithelial–mesenchymal transition and migration capacities of BG‐1 ovarian cancer cells enhanced by E2 (17β‐estradiol) via ER signaling and the downregulation of TGF‐β signal as represented in Table 2 (Kim et al. 2015). Here, ESR1 is linked to ovarian carcinoma.